5 Key Takeaways

• 1

  Pre-myopes are children at risk of developing myopia, identified by factors like family history and visual habits.

• 2

  Randomized controlled trials show treatments like atropine and red light therapy can significantly delay myopia onset.

• 3

  Delaying myopia onset by one year can reduce a patient's final myopia level by at least 0.75D, equating to years of treatment.

• 4

  Novel light therapies, including a virtual reality-like device, are being explored for their effectiveness in myopia management.

• 5

  The landscape of myopia management is expanding with evidence-based treatments and ongoing research into new therapies.